AI "Virtual Biotech" Could Save 9 in 10 Failed Drugs

Stanford researchers built an AI system that mimics a drug company, complete with a virtual chief scientist coordinating specialized AI agents.

This breakthrough could rescue promising treatments that currently fail in clinical trials.